Skip to main content

Table 1 The A-R-CHOP regimen*

From: Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma

Drug

Dose

Mode

 

Bevacizumab†

15 mg/kg

i.v.

D1

Rituximab‡

375 mg/m2

i.v.

D1

Cyclophosphamide

750 mg/m2

i.v.

D1

Doxorubicin

50 mg/m2

i.v.

D1

Vincristine

1.4 mg/m2 (≤2 mg)

i.v.

D1

Prednisone

100 mg/d

p.o.

D1-5

  1. *1 cycle per 21 days †bevacizumab was given prior to rituximab, the infusion time of bevacizumab is one hour. ‡the infusion time of rituximab is five hours.
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us